More research into OI is being done than ever before, and the complex findings and breakthroughs can be hard to decipher. Join the OIF in the first of a new series as we demystify and contextualize medical research in The Current State of OI Research: An Update for the OI Community. This series kicks off on Wishbone Day, May 6 at 6pm ET with a conversation between Cameron Penn, President of the OIF Board of Directors, and Dr. Brendan Lee MD, PhD, Principal Investigator of the Brittle Bones Disorders Consortium and OIF Medical Advisory Council Member.
In this talk, Cameron Penn and Dr. Lee will explore the history of the BBDC, the growth of OI research, and its impact on our understanding of OI.
The Brittle Bone Disorders Consortium is a multi–center initiative that focuses on understanding and providing better treatment options for osteogenesis imperfecta. As a partner of the OIF, it has 3 major goals:
- Gain a better understanding of all genetic forms of OI
- Expand treatment options for those with OI
- Help guide the next generation of physicians and scientists
This series is intended for anyone who wants to learn more about OI medical research, and we courage everyone to attend!